Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Production of Antibiotics

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Isolation and properties of the components of staphylomycin.

Antibiotics & chemotherapy (Northfield, Ill.)·2014

Same author

Microbiologic study of the components of staphylomycin.

Antibiotics & chemotherapy (Northfield, Ill.)·2014

Same author

Replacement of microbiological assays of antibiotics based on high-performance liquid chromatography.

Journal of pharmaceutical and biomedical analysis·1989

Same author

Quantitative analysis of chlortetracycline and related substances by high-performance liquid chromatography.

Journal of pharmaceutical and biomedical analysis·1989

Same author

A collaborative study of the analysis of doxycycline hyclate by high-performance liquid chromatography on polystyrene-divinylbenzene packing materials.

Journal of pharmaceutical and biomedical analysis·1989

Same author

Tissue distribution and excretion of radioactively labelled compounds in the Wistar rat after administration of [N-methyl-14C]-erythromycin A.

European journal of drug metabolism and pharmacokinetics·1989

Search research articles

Related Experiment Video

Updated: Jul 22, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

[Nontraditional beta-lactam antibiotics].

H Vanderhaeghe¹

¹Rega instituut Katholieke Universiteit Leuven.

Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie

|January 1, 1991

Summary

Novel beta-lactam antibiotics, including clavulanic acid, carbapenems like imipenem, and monobactams such as aztreonam, offer new treatments for bacterial infections. These derivatives expand therapeutic options beyond traditional penicillins and cephalosporins.

Area of Science:

Medicinal Chemistry
Microbiology
Pharmacology

Context:

Traditional beta-lactam antibiotics (penicillins, cephalosporins) face resistance due to bacterial enzymes.
Emerging beta-lactam derivatives exhibit unique structures and mechanisms of action.
Clinical introduction of novel beta-lactams necessitates understanding their properties and applications.

Purpose:

To review recent advancements in beta-lactam antibiotic derivatives.
To highlight key structural modifications and their impact on activity.
To discuss the therapeutic potential of new beta-lactam agents.

Summary:

Beta-lactamase inhibitors like clavulanic acid, sulbactam, and tazobactam are combined with penicillins to overcome resistance.
Carbapenems, such as imipenem (derived from thienamycin), provide broad-spectrum activity against Gram-positive and Gram-negative bacteria.

More Related Videos

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Related Experiment Videos

Last Updated: Jul 22, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Monobactams, exemplified by aztreonam, offer targeted efficacy against Gram-negative pathogens and are synthesized via total synthesis.

Impact:

These novel beta-lactams broaden the arsenal against antibiotic-resistant bacteria.
Development of synthetic routes enables large-scale production and further research.
Expanded treatment options improve patient outcomes for various bacterial infections.